miR-34c works downstream of p53 leading to dairy goat male germline stem-cell (mGSCs) apoptosis

Cell Proliferation

Volumn 46, Issue 2, 2013, Pages 223-231

  Li, M ^a   Yu, M ^a   Liu, C ^a   Zhu, H ^a   He, X ^a   Peng, S ^a   Hua, J ^a  

^a NORTHWEST A F UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 34C; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWNSTREAM PROCESSING; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; GERM CELL; GERM LINE; GOAT; IN SITU HYBRIDIZATION; MALE; MALE GERMLINE STEM CELL; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BROMODEOXYURIDINE; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GOATS; IN SITU HYBRIDIZATION; MALE; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; SPERMATOZOA; STEM CELLS; TESTIS; TIME FACTORS; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84875280021     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/cpr.12013     Document Type: Article

References (36)

1. Esquela-Kerscher A, Slack FJ (2006) Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259-269.
2. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer 6, 857-866.
3. Hammond SM (2006) MicroRNAs as oncogenes. Curr. Opin. Genet. Dev. 16, 4-9.
4. Catuogno S, Cerchia L, Romano G, Pognonec P, Condorelli G, de Franciscis V. (2013) miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis. Oncogene 32, 341-351.
5. Corney DC, Flesken-Nikitin A, Godwin AK, Wang W, Nikitin AY (2007) MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res. 67, 8433-8438.
6. He X, He L, Hannon GJ (2007) The guardian's little helper: microRNAs in the p53 tumor suppressor network. Cancer Res. 67, 11099-11101.
7. Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, Menssen A et al. (2007) Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6, 1586-1593.
8. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y et al. (2007) A microRNA component of the p53 tumour suppressor network. Nature 447, 1130-1134.
9. Kumamoto K, Spillare EA, Fujita K, Horikawa I, Yamashita T, Appella E et al. (2008) Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence. Cancer Res. 68, 3193-3203.
10. López JA, Alvarez-Salas LM (2011) Differential effects of miR-34c-3p and miR-34c-5p on SiHa cells proliferation apoptosis, migration and invasion. Biochem. Biophys. Res. Commun. 409, 513-519.
11. Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, Love RE et al. (2007) p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol. 17, 1298-1307.
12. Sharma N, Timmers C, Trikha P, Saavedra HI, Obery A, Leone G (2006) Control of the p53-p21CIP1 Axis by E2f1, E2f2, and E2f3 is essential for G1/S progression and cellular transformation. J. Biol. Chem. 281, 36124-36131.
13. Poyurovsky MV, Prives C (2006) Unleashing the power of p53: lessons from mice and men. Genes Dev. 20, 125-131.
14. Schuler M, Green DR (2001) Mechanisms of p53-dependent apoptosis. Biochem. Soc. Trans. 29, 684-688.
15. Hermeking H (2007) p53 enters the microRNA world. Cancer Cell 12, 414-418.
16. Cannell IG, Kong YW, Johnston SJ, Chen ML, Collins HM, Dobbyn HC et al. (2010) p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication. PNAS 3, 5375-5380.
17. Tazawa H, Tsuchiya N, Izumiya M, Nakagama H (2007) Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc. Natl Acad. Sci. U.S.A. 104, 15472-15477.
18. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N et al. (2007) Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol. Cell 26, 731-743.
19. Liang X, Zhou D, Wei C, Luo H, Liu J, Fu R et al. (2012) MicroRNA-34c enhances murine male germ cell apoptosis through targeting ATF1. PLoS ONE 7, e33861.
20. Bouhallier F, Allioli N, Lavial F (2010) Role of miR-34c microRNA in the late steps of spermatogenesis. RNA 16, 720-731.
21. Hua J, Zhu H, Pan S, Liu C, Sun J, Ma X et al. (2011) Pluripotent male germline stem cells from goat fetal testis and their survival in mouse testis. Cellular Reprogram. 13, 133-144.
22. Zhu H, Liu C, Sun J, Li M, Hua J (2012) Effect of GSK3 inhibitor on the proliferation of multipotent male germline stem cells (mGSCs) derived from goat testis. Theriogenology 77:1939-1950.
23. Li M, Liu C, Zhu H, Sun J, Yu M, Niu Z et al. (2013) Expression pattern of Boule in dairy goat testis and its function in promoting the meiosis in male germline stem cells (mGSCs). J. Cell. Biochem. 114:294-302.
24. Dyce PW, Zhu H, Craig J, Li J (2004) Stem cells with multilineage potential derived from porcine skin. Biochem. Biophys. Res. Commun. 316, 651-658.
25. Mussmann R, Geese M, Harder F, Kegel S, Andag U (2007) Inhibition of GSK3 promotes replication and survival of pancreatic beta cells. J. Biol. Chem. 282, 12030-12037.
26. Hu Y, Bai Y, Chu Z, Wang J, Wang L, Yu M et al. (2012) GSK3 inhibitor-BIO regulates proliferation of female germline stem cells from the postnatal mouse ovary. Cell Prolif. 45, 287-298.
27. Yamamura S, Saini S, Majid S, Hirata H, Ueno K, Deng G et al. (2012) MicroRNA-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cells. PLoS ONE 7, e29722.
28. Valencia-Sanchez MA, Liu J, Hannon GJ (2006) Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 20, 515.
29. Ahmed FE (2007) Role of miRNA in carcinogenesis and biomarker selection: a methodological view. Expert Rev. Mol. Diagn. 7, 56.
30. Zhang L, Huang J, Yang N (2006) microRNAs exhibit high frequency genomic alterations in human cancer. Proc. Natl Acad. Sci. U.S.A. 103, 9136-9141.
31. Calin GA, Ferracin M, Cimmino A (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med. 353, 1793-1801.
32. Saito Y, Liang G, Egger G (2006) Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9, 435-443.
33. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature 43, 839-843.
34. Yamakuchi M, Ferlito M, Charles J (2008) Lowenstein miR-34a repression of SIRT1 regulates apoptosis. PNAS 36, 13421-13426.
35. Dong F, Lou D (2012) MicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targets. Mol. Vis. 18, 537-546.
36. Rokhlin OW, Scheinker VS, Taghiyev AF, Bumcrot D, Glover RA, Cohen MB (2008) MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer. Cancer Biol. Ther. 7, 1288-1296.